Levomethadone
NERVOUS SYSTEM
Also known as: levomethadone HCl, levomethadone hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Levomethadone is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including Oprd1|Oprm1|Oprk1|Sigmar1. Recorded indications include Opioid dependence.
- Molecular targets: Oprd1|Oprm1|Oprk1|Sigmar1 (1 listed in DrugCentral).
- Indications: Opioid dependence.
- ATC code: N07BC05 (Drugs used in opioid dependence).
- Molecular formula: C21H27NO; molecular weight 309.45 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Opioid dependence
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Opioid receptor | Oprd1|Oprm1|Oprk1|Sigmar1 | unknown | Ki 8.70 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N07BC05 | NERVOUS SYSTEM › OTHER NERVOUS SYSTEM DRUGS › DRUGS USED IN ADDICTIVE DISORDERS › Drugs used in opioid dependence |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Aggression | 408.5 |
| Drug abuse | 402.4 |
| Substance abuse | 386.0 |
| Logorrhoea | 227.1 |
| Restlessness | 226.0 |
| Abnormal behaviour | 221.6 |
| Bradykinesia | 194.1 |
| Drug dependence | 193.3 |
| Patient uncooperative | 191.3 |
| Bradyphrenia | 159.4 |
| Dysarthria | 158.6 |
| Psychotic behaviour | 114.0 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Levomethadone is on its molecule page.
| Molecular formula | C21H27NO |
|---|---|
| Molecular weight | 309.45 g/mol |
| CAS number | 125-58-6 |
| InChIKey | USSIQXCVUWKGNF-QGZVFWFLSA-N |
| PubChem CID | 22267 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Levomethadone used for?
DrugCentral lists the following indications for Levomethadone: Opioid dependence.
How does Levomethadone work?
Its molecular targets in DrugCentral include Oprd1|Oprm1|Oprk1|Sigmar1.
What is the chemical formula of Levomethadone?
Levomethadone has the molecular formula C21H27NO and a molecular weight of 309.45 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4586 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL159659 — compound record and bioactivity
- PubChem CID 22267 — chemical identifiers
- DrugBank DB13515 — drug record
- FDA UNII 6Y75Z4E8NS — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.